| RS2509130428 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509130471 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509130611 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509133581 |
SGCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509133663 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509135035 |
RAD51D
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2509135094 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS2509135407 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509135478 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509137669 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509137893 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509138759 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509140612 |
CLTC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509142628 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509142706 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS2509142747 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509142832 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509143037 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509143087 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509143271 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS2509143339 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS2509143386 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509144215 |
CLTC
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 56 |
| RS2509150097 |
CLTC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509150617 |
CLTC
|
Health Risk |
Likely pathogenic |
— |
| RS2509150764 |
CLTC
|
Health Risk |
Likely pathogenic |
— |
| RS2509151066 |
CLTC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509151608 |
CLTC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509151829 |
CLTC
|
Health Risk |
Likely pathogenic |
— |
| RS2509152668 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509152675 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509152697 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS2509152842 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2509153423 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509153473 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509153854 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509154133 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509155001 |
CLTC
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 56 |
| RS2509155128 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS2509155514 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509155618 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509155661 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509156659 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509156967 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509156997 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509157043 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509157160 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509157685 |
CLTC
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2509157718 |
COL1A1
|
Health Risk |
Pathogenic |
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1, Osteogenesis imperfecta type I |
| RS2509157723 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509157877 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509158550 |
CLTC
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2509158651 |
CLTC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509158820 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS2509159489 |
COL1A1
|
Health Risk |
Likely pathogenic |
COL1A1-related disorder, COL1A1-related disorder |
| RS2509159584 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509159786 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2509160384 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509160982 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509161006 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS2509161402 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509161596 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509161707 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509162830 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509162962 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509163856 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509163875 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509163924 |
COL1A1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2509164332 |
COL1A1
|
Health Risk |
Likely pathogenic |
COL1A1-related disorder, COL1A1-related disorder |
| RS2509165121 |
CLTC
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2509165203 |
CLTC
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2509165406 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509165452 |
COL1A1
|
Health Risk |
Likely pathogenic |
COL1A1-related disorder, COL1A1-related disorder |
| RS2509165688 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509166330 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509166433 |
COL1A1
|
Health Risk |
Likely pathogenic |
COL1A1-related disorder, COL1A1-related disorder |
| RS2509166526 |
COL1A1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2509166957 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509167080 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509167461 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509167969 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509168063 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509168093 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509168104 |
PEX12
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder type 3B |
| RS2509168202 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509168351 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509168475 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509169443 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509169504 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509169652 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509169676 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), PEX12-related disorder |
| RS2509169855 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509169869 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509169901 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509169974 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2509170044 |
COL1A1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2509170063 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS2509170081 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509170117 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2509170188 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |